Pradžia › Neuroblastoma › Arkansas
Neuroblastoma klinikiniai tyrimai Arkansas
6 tyrimai dėl Neuroblastoma ieško dalyvių vietose Arkansas.
Miestai Arkansas
Oficialus tyrimo tekstas (anglų kalba)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Arkansas Children's Hospital, Little Rock
Renkami dalyviai3 fazė
Iki 30 metų · Visoms lytims · Atnaujinta 2026-10-02 · NCT06172296Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Arkansas Children's Hospital, Little Rock
Renkami dalyviai2 fazė
Iki 22 metų · Visoms lytims · Atnaujinta 2026-09-04 · NCT02559778Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Arkansas Children's Hospital, Little Rock
Renkami dalyviai1/2 fazė
Iki 26 metų · Visoms lytims · Atnaujinta 2026-09-03 · NCT06465199Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
- Arkansas Children's Hospital, Little Rock
Renkami dalyviai2 fazė
Amžius nuo 1 iki 21 · Visoms lytims · Atnaujinta 2026-09-03 · NCT06540963Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Arkansas Children's Hospital, Little Rock
Renkami dalyviai3 fazė
365 Days – 30 Years · Visoms lytims · Atnaujinta 2026-08-25 · NCT03126916Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Arkansas Children's Hospital, Little Rock
Renkami dalyviai2 fazė
12 Months – 21 Years · Visoms lytims · Atnaujinta 2026-08-12 · NCT05489887Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.